Clorox (CLX) Stock May Be 35% Undervalued As Earnings Near
After several years where Clorox stock has fallen about 38% over 5 years, current valuation checks point in the opposite direction, with both the Discounted Cash Flow (DCF) intrinsic value estimate and market multiples suggesting the shares may now be pricing in relatively low expectations.
- The share price decline of roughly 38.2% over 5 years signals that investors have been marking Clorox down, even before considering today’s valuation signals.
- Expectations for pressured margins and softer sales, including the impact of higher manufacturing and logistics costs and the GOJO Industries acquisition, can support a cautious outlook on earnings. At the same time, a high dividend payout ratio raises the risk that the current 5% yield may be hard to maintain.
- Clorox screens as undervalued on most of Simply Wall St’s checks, with the broader framework suggesting the stock leans cheap in 5 of 6 valuation tests according to the valuation score.
The issue now is whether the current discount signaled by the intrinsic value estimate and multiples offers enough compensation for the earnings and dividend risks facing Clorox.
Find out why Clorox's -21.6% return over the last year is lagging behind its peers.
Does Clorox Look Undervalued on Cash Flow?
The Discounted Cash Flow (DCF) model estimates what Clorox might be worth based on its future cash generation. For Clorox, the latest twelve month free cash flow sits around $370.8m, and the model assumes that cash flows recover over time rather than shrink sharply. On those projections, the 2 Stage Free Cash Flow to Equity approach points to an intrinsic value of about $148.71 per share in dollar terms.
That intrinsic estimate sits roughly 35.2% above the current share price. This suggests the stock is trading below what its projected cash flows support. The recent guidance cuts around sales declines, margin pressure and the GOJO acquisition help explain why the market is keeping a discount in place, even though the DCF outcome implies the current price could be conservative.
Overall, the DCF analysis indicates that Clorox stock currently screens as undervalued relative to its modeled cash flow outlook.
Our Discounted Cash Flow (DCF) analysis suggests Clorox is undervalued by 35.2%. Track this in your watchlist or portfolio, or discover 47 more high quality undervalued stocks.
Does Clorox Look Undervalued on Earnings?
The P/E ratio is a useful cross check for Clorox because earnings tend to be the main focus for established consumer staples stocks. Clorox currently trades on a P/E of 15.4x, which sits below both the Household Products industry average of 17.0x and the broader peer group average of 26.7x. This suggests the market is applying a softer earnings multiple to Clorox than many comparable companies.
Simply Wall St’s fair P/E ratio for Clorox is 18.3x, based on factors such as its industry, size, margins and risk profile. Compared with that yardstick, the current 15.4x implies a gap that points to the stock trading at a discount relative to where this framework would typically place it.
On the P/E multiple, Clorox stock currently appears undervalued compared with both its tailored fair ratio and key peers.
See what the numbers say about this price — find out in our valuation breakdown.
The Clorox Narrative: What Would Justify Today's Price?
Simply Wall St Narratives for Clorox pick up where the valuation puzzle leaves off by explaining which paths for Clorox's growth, margins and earnings would need to unfold for the stock to be worth materially more or less than today’s price. Each narrative links a fair value estimate to a specific storyline about Clorox's potential catalysts and risks, so you can monitor over time which version of events appears to be taking shape on the Community page.
Community views on Clorox are split between those who see reset expectations as an entry point and those who think execution risks still loom large.
Bull case: 9% undervalued
"The full-scale implementation of a modern ERP system is expected to drive long-term operational efficiencies, improving supply chain visibility, speeding innovation cycles, and reducing structural costs..."
Read the full Bull Case to see why Clorox could be undervalued
Bear case: 25% overvalued
"The proliferation of private label and online-native competitors, accelerated by digital channel growth and aggressive discounting in key categories like trash bags and cat litter, is expected to erode brand loyalty..."
Read the full Bear Case to see why Clorox could be overvalued
Do you think there's more to the story for Clorox? Head over to our Community to see what others are saying!
The Bottom Line
For Clorox, both the Discounted Cash Flow (DCF) intrinsic value estimate and the earnings multiple view currently point in the same direction, with the stock screening as undervalued on each framework. Together, they suggest the market is pricing in cautious assumptions on margins, cash generation and the dividend.
The key question from here is whether Clorox can stabilise profitability and protect its payout without further strain from cost pressures and integration of the GOJO acquisition. That execution risk is what will decide whether today’s discount is an opportunity or a value trap that correctly reflects the underlying challenges.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com